Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Smad2 and Smad3 are essential for normal skin development, and their absence causes severe skin issues and cancer.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Understanding tissue remodeling can help create precise treatments for various organ issues.

Berberine may reduce prostate enlargement by blocking inflammation.

Researchers found genes and microRNAs that control curly fleece in Chinese Tan sheep.

Lrig1 marks a unique group of stem cells in mouse skin that can become different skin cell types.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

TGF-β is crucial for controlling stem cell behavior and changes in its signaling can lead to diseases like cancer.

Wnt signaling is crucial for bone regeneration.

MOF controls key genes for skin development by regulating mitochondrial and ciliary functions.

Krt6a-Cre transgenic mice help study gene effects on hair follicle development and tumor suppression.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

TCF/Lef1 activity is essential for proper skin cell development and renewal.

LncRNA MSTRG.14227.1 hinders hair follicle development in cashmere goats, affecting cashmere quality.